1-[5-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-1-methylpyrazol-3-yl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;tert-butyl N-[4-[[8-ethyl-6-[1-methyl-3-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoylamino]pyrazol-5-yl]quinazolin-2-yl]amino]cyclohexyl]carbamate

C73H94F6N20O4 — CID 161073749

IUPAC1-[5-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-1-methylpyrazol-3-yl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;tert-butyl N-[4-[[8-ethyl-6-[1-methyl-3-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoylamino]pyrazol-5-yl]quinazolin-2-yl]amino]cyclohexyl]carbamate
SMILESCCc1cc(-c2cc(NC(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)nn2C)cc2cnc(NC3CCC(N)CC3)nc12.CCc1cc(-c2cc(NC(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)nn2C)cc2cnc(NC3CCC(NC(=O)OC(C)(C)C)CC3)nc12
InChIInChI=1S/C39H51F3N10O3.C34H43F3N10O/c1-7-24-18-26(19-27-22-43-35(48-34(24)27)44-28-10-12-29(13-11-28)46-37(54)55-38(2,3)4)32-21-33(49-51(32)6)47-36(53)45-30-9-8-25(31(20-30)39(40,41)42)23-52-16-14-50(5)15-17-52;1-4-21-15-23(16-24-19-39-32(43-31(21)24)40-26-9-6-25(38)7-10-26)29-18-30(44-46(29)3)42-33(48)41-27-8-5-22(28(17-27)34(35,36)37)20-47-13-11-45(2)12-14-47/h8-9,18-22,28-29H,7,10-17,23H2,1-6H3,(H,46,54)(H,43,44,48)(H2,45,47,49,53);5,8,15-19,25-26H,4,6-7,9-14,20,38H2,1-3H3,(H,39,40,43)(H2,41,42,44,48)
InChIKeyUEZLYQKVIHFSSR-UHFFFAOYSA-N
MW1429.68 g/mol
LogP12.94
Rot. Bonds17

About 1-[5-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-1-methylpyrazol-3-yl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;tert-butyl N-[4-[[8-ethyl-6-[1-methyl-3-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoylamino]pyrazol-5-yl]quinazolin-2-yl]amino]cyclohexyl]carbamate

1-[5-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-1-methylpyrazol-3-yl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;tert-butyl N-[4-[[8-ethyl-6-[1-methyl-3-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoylamino]pyrazol-5-yl]quinazolin-2-yl]amino]cyclohexyl]carbamate (PubChem CID 161073749) has the molecular formula C73H94F6N20O4 and a molecular weight of 1429.68 g/mol. Its IUPAC name is 1-[5-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-1-methylpyrazol-3-yl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;tert-butyl N-[4-[[8-ethyl-6-[1-methyl-3-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoylamino]pyrazol-5-yl]quinazolin-2-yl]amino]cyclohexyl]carbamate.

Molecular Properties

Compound Name1-[5-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-1-methylpyrazol-3-yl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;tert-butyl N-[4-[[8-ethyl-6-[1-methyl-3-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoylamino]pyrazol-5-yl]quinazolin-2-yl]amino]cyclohexyl]carbamate
PubChem CID161073749
Molecular FormulaC73H94F6N20O4
Molecular Weight1429.68 g/mol
Exact Mass1428.77
IUPAC Name1-[5-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-1-methylpyrazol-3-yl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;tert-butyl N-[4-[[8-ethyl-6-[1-methyl-3-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoylamino]pyrazol-5-yl]quinazolin-2-yl]amino]cyclohexyl]carbamate
SMILESCCc1cc(-c2cc(NC(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)nn2C)cc2cnc(NC3CCC(N)CC3)nc12.CCc1cc(-c2cc(NC(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)nn2C)cc2cnc(NC3CCC(NC(=O)OC(C)(C)C)CC3)nc12
InChIInChI=1S/C39H51F3N10O3.C34H43F3N10O/c1-7-24-18-26(19-27-22-43-35(48-34(24)27)44-28-10-12-29(13-11-28)46-37(54)55-38(2,3)4)32-21-33(49-51(32)6)47-36(53)45-30-9-8-25(31(20-30)39(40,41)42)23-52-16-14-50(5)15-17-52;1-4-21-15-23(16-24-19-39-32(43-31(21)24)40-26-9-6-25(38)7-10-26)29-18-30(44-46(29)3)42-33(48)41-27-8-5-22(28(17-27)34(35,36)37)20-47-13-11-45(2)12-14-47/h8-9,18-22,28-29H,7,10-17,23H2,1-6H3,(H,46,54)(H,43,44,48)(H2,45,47,49,53);5,8,15-19,25-26H,4,6-7,9-14,20,38H2,1-3H3,(H,39,40,43)(H2,41,42,44,48)
InChIKeyUEZLYQKVIHFSSR-UHFFFAOYSA-N
XLogP12.94
TPSA270.83 Ų
H-Bond Donors8
H-Bond Acceptors19
Rotatable Bonds17
Heavy Atoms103
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001429.68
LogP ≤ 512.94
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1019

Analyze 1-[5-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-1-methylpyrazol-3-yl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;tert-butyl N-[4-[[8-ethyl-6-[1-methyl-3-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoylamino]pyrazol-5-yl]quinazolin-2-yl]amino]cyclohexyl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[5-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-1-methylpyrazol-3-yl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;tert-butyl N-[4-[[8-ethyl-6-[1-methyl-3-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoylamino]pyrazol-5-yl]quinazolin-2-yl]amino]cyclohexyl]carbamate?
The IUPAC name of 1-[5-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-1-methylpyrazol-3-yl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;tert-butyl N-[4-[[8-ethyl-6-[1-methyl-3-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoylamino]pyrazol-5-yl]quinazolin-2-yl]amino]cyclohexyl]carbamate (CID 161073749) is 1-[5-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-1-methylpyrazol-3-yl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;tert-butyl N-[4-[[8-ethyl-6-[1-methyl-3-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoylamino]pyrazol-5-yl]quinazolin-2-yl]amino]cyclohexyl]carbamate.
What is the SMILES notation for 1-[5-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-1-methylpyrazol-3-yl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;tert-butyl N-[4-[[8-ethyl-6-[1-methyl-3-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoylamino]pyrazol-5-yl]quinazolin-2-yl]amino]cyclohexyl]carbamate?
The canonical SMILES for 1-[5-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-1-methylpyrazol-3-yl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;tert-butyl N-[4-[[8-ethyl-6-[1-methyl-3-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoylamino]pyrazol-5-yl]quinazolin-2-yl]amino]cyclohexyl]carbamate is CCc1cc(-c2cc(NC(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)nn2C)cc2cnc(NC3CCC(N)CC3)nc12.CCc1cc(-c2cc(NC(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)nn2C)cc2cnc(NC3CCC(NC(=O)OC(C)(C)C)CC3)nc12.
What is the InChIKey of 1-[5-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-1-methylpyrazol-3-yl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;tert-butyl N-[4-[[8-ethyl-6-[1-methyl-3-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoylamino]pyrazol-5-yl]quinazolin-2-yl]amino]cyclohexyl]carbamate?
The InChIKey is UEZLYQKVIHFSSR-UHFFFAOYSA-N. The full InChI is InChI=1S/C39H51F3N10O3.C34H43F3N10O/c1-7-24-18-26(19-27-22-43-35(48-34(24)27)44-28-10-12-29(13-11-28)46-37(54)55-38(2,3)4)32-21-33(49-51(32)6)47-36(53)45-30-9-8-25(31(20-30)39(40,41)42)23-52-16-14-50(5)15-17-52;1-4-21-15-23(16-24-19-39-32(43-31(21)24)40-26-9-6-25(38)7-10-26)29-18-30(44-46(29)3)42-33(48)41-27-8-5-22(28(17-27)34(35,36)37)20-47-13-11-45(2)12-14-47/h8-9,18-22,28-29H,7,10-17,23H2,1-6H3,(H,46,54)(H,43,44,48)(H2,45,47,49,53);5,8,15-19,25-26H,4,6-7,9-14,20,38H2,1-3H3,(H,39,40,43)(H2,41,42,44,48).
What are the key properties of 1-[5-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-1-methylpyrazol-3-yl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;tert-butyl N-[4-[[8-ethyl-6-[1-methyl-3-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoylamino]pyrazol-5-yl]quinazolin-2-yl]amino]cyclohexyl]carbamate?
1-[5-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-1-methylpyrazol-3-yl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;tert-butyl N-[4-[[8-ethyl-6-[1-methyl-3-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoylamino]pyrazol-5-yl]quinazolin-2-yl]amino]cyclohexyl]carbamate has a molecular weight of 1429.68 g/mol, XLogP of 12.94, 17 rotatable bonds, 8 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[5-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-1-methylpyrazol-3-yl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;tert-butyl N-[4-[[8-ethyl-6-[1-methyl-3-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoylamino]pyrazol-5-yl]quinazolin-2-yl]amino]cyclohexyl]carbamate is sourced from PubChem (CID 161073749), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).